StockMacro
Menu

CeriBell

$27.39 +46% in 6 monthsMarket cap $1.1B

CBLL on XNAS, Health Care, CeriBell, Inc., job postings

Measures activity, not value. Not investment advice.

Revenue rose 31% to $108.7M, but losses reached $73.9M while free cash flow was -$56.4M.

  • GoodLatest quarter revenue rose 30% to $29.3M from $22.6M
  • GoodInstitutional holders rose to 132 from 122 in one quarter

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.

Industry
Electromedical & electrotherapeutic apparatus (Health Care)
Employees
300
Website
ceribell.com
Listed
Nasdaq, US
Last results
3 Nov 2026
Next results
expected around 23 Feb 2027 (an estimate: a year ago it reported on 24 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $29.3M, net loss $21.4M.
Quarter to 31 Mar 2023: revenue –, net income -$7.9MQuarter to 30 Jun 2023: revenue –, net income -$6.2MQuarter to 30 Sep 2023: revenue $11.6M, net income -$7.1MQuarter to 30 Sep 2023: revenue $11.6M, net income -$7.1MQuarter to 31 Dec 2023: revenue $13.1M, net income -$8.3MQuarter to 31 Dec 2023: revenue $13.1M, net income -$8.3MQuarter to 31 Mar 2024: revenue $14.4M, net income -$8.5MQuarter to 31 Mar 2024: revenue $14.4M, net income -$8.5MQuarter to 30 Jun 2024: revenue $15.3M, net income -$8.9MQuarter to 30 Jun 2024: revenue $15.3M, net income -$8.9MQuarter to 30 Sep 2024: revenue $17.2M, net income -$10.4MQuarter to 30 Sep 2024: revenue $17.2M, net income -$10.4MQuarter to 31 Dec 2024: revenue $18.5M, net income -$12.6MQuarter to 31 Dec 2024: revenue $18.5M, net income -$12.6MQuarter to 31 Mar 2025: revenue $20.5M, net income -$12.8MQuarter to 31 Mar 2025: revenue $20.5M, net income -$12.8MQuarter to 30 Jun 2025: revenue $21.2M, net income -$13.6MQuarter to 30 Jun 2025: revenue $21.2M, net income -$13.6MQuarter to 30 Sep 2025: revenue $22.6M, net income -$13.5MQuarter to 30 Sep 2025: revenue $22.6M, net income -$13.5MQuarter to 31 Dec 2025: revenue $24.8M, net income -$13.5MQuarter to 31 Dec 2025: revenue $24.8M, net income -$13.5MQuarter to 31 Mar 2026: revenue $26.5M, net income -$19.7MQuarter to 31 Mar 2026: revenue $26.5M, net income -$19.7MQuarter to 30 Jun 2026: revenue $28.1M, net income -$19.3MQuarter to 30 Jun 2026: revenue $28.1M, net income -$19.3MQuarter to 30 Sep 2026: revenue $29.3M, net income -$21.4MQuarter to 30 Sep 2026: revenue $29.3M, net income -$21.4M
31 Mar 2023RevenueNet incomeNet losstallest bar $29.3M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$29.3M-$21.4M
30 Jun 2026$28.1M-$19.3M
31 Mar 2026$26.5M-$19.7M
31 Dec 2025$24.8M-$13.5M
30 Sep 2025$22.6M-$13.5M
30 Jun 2025$21.2M-$13.6M
31 Mar 2025$20.5M-$12.8M
31 Dec 2024$18.5M-$12.6M
30 Sep 2024$17.2M-$10.4M
30 Jun 2024$15.3M-$8.9M
31 Mar 2024$14.4M-$8.5M
31 Dec 2023$13.1M-$8.3M
30 Sep 2023$11.6M-$7.1M
30 Jun 2023–-$6.2M
31 Mar 2023–-$7.9M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $108.7M $82.8M
Revenue growthRevenue of the last 12 months compared with the 12 months before. +31% +19%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$73.9M -$52.5M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). -$1.94 $0.52
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 89.3% 88.0% 61.8%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. -69.8% -68.5% -24.9%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. -68.0% -63.3% -33.5%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. -52.5% -77.7%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. -$56.4M -$41.0M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $117.5M $168.5M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $20.0M $19.7M
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). -$97.5M (net cash) -$148.8M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.17 0.32
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $3.03
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 24.4
P/SPrice to sales: market cap divided by revenue of the last 12 months. 9.8 3.0
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 8.9 2.6
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 9.0 3.6

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
CeriBellCBLL (this company) $1.1Bloss9.8+31%-68.0%
ConmedCNMD $1.4B––––
TransMedicsTMDX $3.0B20.54.1+28%19.9%
AxogenAXGN $3.3Bloss12.5+24%-12.0%
CapsoVisionCV $327.6Mloss23.5+6.4%-210%
IntegerITGR $4.3B41.62.4-0.3%5.7%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

-$3.8M

bought $0, sold $3.8M

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+8.2%

132 13F filers vs 122

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

81%

31.6M shares held by 13F filers (30 Sep 2026) of 38.8M outstanding (30 Oct 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

5.0%

2.0M shares sold short (30 Oct 2026) of 38.8M outstanding (30 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

3.5

2.0M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-9.2%

2.2M shares sold short in the report before, 2.0M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

71%

71% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 49%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

36

Tracked since 20 Nov 2026

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

Tracking started 20 Nov 2026; the change shows after 30 days.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+30%

$29.3M vs $22.6M (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

–

No data for this company

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

$3.1M

the 12 months before: $0

Lobbying What the company reported spending on federal lobbying over the last four quarters.

–

No data for this company

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

2

2 articles in the last 7 days; its usual week has 0 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

–

2 articles in the last 7 days; its usual week has 0: fewer than one, so there is nothing to compare with.

Price $27.39 on 20 Nov 2026, +101% over 12 months (12-month range $13.64 to $28.27)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders sold a net $23.6M in the last 12 months (the 12 months before: -$3.6M).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 9 published in the last 12 months, +29% on the 12 months before.
Revenue per quarter. Revenue $29.3M in the latest quarter, +30% on a year earlier.
Capital spending per quarter. Capital spending $100K in the latest quarter, -73% on a year earlier.
Institutional holders (13F filers). 132 13F filers reported holding it in the latest 13F quarter, +39% on a year earlier.
Federal obligations. Federal obligations: $2.9M published in the last 12 months, +266% on the 12 months before.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
29 Jul 20268-K and other filingsDirector or officer change
29 Jul 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
2 Jan 20268-K and other filingsDirector or officer change
2 Jan 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
22 Sep 20258-K and other filingsDirector or officer change
22 Sep 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
14 Mar 20258-K and other filingsDirector or officer change
14 Mar 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
9 Oct 20248-K and other filingsRegistered new securities for sale (S-1)
7 Oct 20248-K and other filingsRegistered new securities for sale (S-1)
19 Sep 20248-K and other filingsRegistered new securities for sale (S-1)
26 Aug 20248-K and other filingsRegistered new securities for sale (S-1)
Insider net buying (open market)
Month from 1 Oct 2024: $10.5M published
Month from 1 Apr 2025: -$377K published
Month from 1 May 2025: -$424K published
Month from 1 Jun 2025: -$1.1M published
Month from 1 Jul 2025: -$442K published
Month from 1 Aug 2025: -$93K published
Month from 1 Sep 2025: -$144K published
Month from 1 Oct 2025: -$139K published
Month from 1 Nov 2025: -$893K published
Month from 1 Dec 2025: -$3.7M published
Month from 1 Jan 2026: -$2.7M published
Month from 1 Feb 2026: -$1.7M published
Month from 1 Mar 2026: -$979K published
Month from 1 Apr 2026: -$924K published
Month from 1 May 2026: -$1.2M published
Month from 1 Jun 2026: -$816K published
Month from 1 Jul 2026: -$4.9M published
Month from 1 Aug 2026: -$3.0M published
Month from 1 Sep 2026: -$1.9M published
Month from 1 Oct 2026: -$119K published
Month from 1 Nov 2026: -$1.5M published
H-1B/E-3 applications certified
Quarter from 1 Jul 2022: 2 published
Quarter from 1 Oct 2022: 1 published
Quarter from 1 Jan 2024: 1 published
Quarter from 1 Apr 2024: 2 published
Quarter from 1 Jul 2024: 1 published
Quarter from 1 Jan 2025: 1 published
Quarter from 1 Apr 2025: 1 published
Quarter from 1 Jul 2025: 3 published
Quarter from 1 Oct 2025: 2 published
Quarter from 1 Jan 2026: 4 published
Quarter from 1 Apr 2026: 1 published
Quarter from 1 Jul 2026: 3 published
Quarter from 1 Oct 2026: 1 published
Revenue per quarter
Quarter ended 30 Sep 2023: $11.6M; public on 13 Nov 2024
Quarter ended 31 Dec 2023: $13.1M; public on 26 Feb 2025
Quarter ended 31 Mar 2024: $14.4M; public on 9 May 2025
Quarter ended 30 Jun 2024: $15.3M; public on 6 Aug 2025
Quarter ended 30 Sep 2024: $17.2M, +48% on a year earlier; public on 13 Nov 2024
Quarter ended 31 Dec 2024: $18.5M, +41% on a year earlier; public on 26 Feb 2025
Quarter ended 31 Mar 2025: $20.5M, +42% on a year earlier; public on 9 May 2025
Quarter ended 30 Jun 2025: $21.2M, +38% on a year earlier; public on 6 Aug 2025
Quarter ended 30 Sep 2025: $22.6M, +31% on a year earlier; public on 5 Nov 2025
Quarter ended 31 Dec 2025: $24.8M, +34% on a year earlier; public on 25 Feb 2026
Quarter ended 31 Mar 2026: $26.5M, +29% on a year earlier; public on 12 May 2026
Quarter ended 30 Jun 2026: $28.1M, +33% on a year earlier; public on 11 Aug 2026
Quarter ended 30 Sep 2026: $29.3M, +30% on a year earlier; public on 4 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2023: $477K; public on 26 Feb 2025
Quarter ended 31 Mar 2024: $95K; public on 9 May 2025
Quarter ended 30 Jun 2024: $321K; public on 6 Aug 2025
Quarter ended 30 Sep 2024: $567K; public on 13 Nov 2024
Quarter ended 31 Dec 2024: $357K, -25% on a year earlier; public on 26 Feb 2025
Quarter ended 31 Mar 2025: $148K, +56% on a year earlier; public on 9 May 2025
Quarter ended 30 Jun 2025: $71K, -78% on a year earlier; public on 6 Aug 2025
Quarter ended 30 Sep 2025: $369K, -35% on a year earlier; public on 5 Nov 2025
Quarter ended 31 Dec 2025: $179K, -50% on a year earlier; public on 25 Feb 2026
Quarter ended 31 Mar 2026: $125K, -16% on a year earlier; public on 12 May 2026
Quarter ended 30 Jun 2026: $17K, -76% on a year earlier; public on 11 Aug 2026
Quarter ended 30 Sep 2026: $100K, -73% on a year earlier; public on 4 Nov 2026
Institutional holders (13F filers)
31 Dec 2024 report: 77; public on 14 Feb 2025
31 Mar 2025 report: 85; public on 15 May 2025
30 Jun 2025 report: 91; public on 14 Aug 2025
30 Sep 2025 report: 95; public on 14 Nov 2025
31 Dec 2025 report: 111; public on 17 Feb 2026
31 Mar 2026 report: 116; public on 15 May 2026
30 Jun 2026 report: 122; public on 14 Aug 2026
30 Sep 2026 report: 132; public on 16 Nov 2026
Federal obligations
Month from 1 Mar 2022: $24K published
Month from 1 May 2022: $13K published
Month from 1 Mar 2023: $44K published
Month from 1 Aug 2024: $521K published
Month from 1 Sep 2024: $0 published
Month from 1 Apr 2025: $0 published
Month from 1 Oct 2025: $726K published
Month from 1 Nov 2025: $69K published
Month from 1 Jan 2026: $346K published
Month from 1 Jul 2026: $2.0M published
Month from 1 Oct 2026: $583K published

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is research and development expense, quarter at $7.4M (30 Sep 2026), 1.8× its normal quarter; higher than 100% of its own history.
  • Insider net buying (open market): Insiders sold a net $23.6M in the last 12 months (the 12 months before: -$3.6M).
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 9 published in the last 12 months, +29% on the 12 months before.
  • Revenue per quarter: Revenue $29.3M in the latest quarter, +30% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 80 insider trades

Last 90 days: 16 sales, $3.8M; no purchases. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
17 Nov 2026Josef ParviziDirectorSellplanned in advance (10b5-1)25,000$26.02$650KForm 4
13 Nov 2026William W BurkeDirectorSellplanned in advance (10b5-1); after exercising options18,000$26.64$479KForm 4
10 Nov 2026Joseph Michael TaylorDirectorSell10,200$27.22$278KForm 4
4 Nov 2026Raymond WooChief Technology OfficerSellplanned in advance (10b5-1); after exercising options4,887$26.96$132KForm 4
2 Oct 2026Raymond WooChief Technology OfficerSellplanned in advance (10b5-1); after exercising options4,887$24.38$119KForm 4
17 Sep 2026Xingjuan ChaoPresident and CEOSellplanned in advance (10b5-1)20,846$25.03$522KForm 4
17 Sep 2026Scott BlumbergChief Financial OfficerSellplanned in advance (10b5-1); after exercising options846$25.00$21KForm 4
10 Sep 2026Raymond WooChief Technology OfficerSellplanned in advance (10b5-1); after exercising options4,887$24.33$119KForm 4

132 institutions reported shares at the end of Q3 2026, 81% of the shares outstanding; 23 opened a position, 12 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
FMR LLC (Fidelity)6.3M16.3%$154.3M+635K+11%
Red Tree Management, LLC2.2M5.68%$53.8MNo change
BlackRock, Inc.2.1M5.44%$51.5M+177K+9.2%
TPG GP A, LLC2.0M5.24%$49.7M-1.7M-46%
Vanguard Capital Management LLC1.4M3.48%$33.0M+222K+20%
KCM Capital Inc1.1M2.96%$28.0M+25K+2.2%
Federated Hermes, Inc.939K2.42%$22.9M-3490%
Franklin Templeton Inc922K2.37%$25.3M+3,965+0.4%
Adage Capital Partners GP, L.L.C.900K2.32%$22.0MNo change
TimesSquare Capital Management, LLC783K2.02%$19.1M+2,347+0.3%

Company events

All 12 company events

In 12 months: 2 director or officer changes, 1 major agreement. Results releases and routine reports are left out.

FiledWhat happenedSource
29 Jul 2026Director or officer change8-K
2 Jan 2026Director or officer change8-K
12 Dec 2025Signed a major agreement8-K
24 Sep 2025Signed a major agreement8-K
22 Sep 2025Director or officer change8-K
20 Jun 2025Signed a major agreement8-K
14 Mar 2025Director or officer change8-K
9 Oct 2024Registered new securities for sale (S-1)S-1/A

36 open postings; careers site tracked since 20 Nov 2026. Most in Sales & business development 58%, Operations & administration 19%, Product management 6%, Research & science 6%.

PostedJobLocation
18 Nov 2026Territory Manager - Long IslandSales & business developmentLong Island, New York
17 Nov 2026Territory Manager - ArizonaSales & business developmentPhoenix, Arizona
13 Nov 2026Sr. Manager of Commercial Strategy and OperationsOperations & administrationSunnyvale, CA
11 Nov 2026Head of Medical Affairs (Hybrid/Remote)Operations & administrationSunnyvale, CA
10 Nov 2026Territory Manager - St. Louis, MOSales & business developmentSt. Louis, Missouri
9 Nov 2026Clinical Account Manager- SacramentoSales & business developmentSacramento
5 Nov 2026Vice President, Market Access (Hybrid/Remote)Operations & administrationSunnyvale, CA
4 Nov 2026Sr. Director / Vice President, Strategic Finance & Analytics (Hybrid)Finance & accountingSunnyvale, CA

The 5 newest of 46 articles that name the company.

Timeline
Kind of data

Timeline

Changes and notable records, by the date each became public

  1. 29 Jul 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  2. 29 Jul 2026Filings record

    Director or officer change

  3. 2 Jan 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  4. 2 Jan 2026Filings record

    Director or officer change

  5. 22 Sep 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  6. 22 Sep 2025Filings record

    Director or officer change

  7. 14 Mar 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  8. 14 Mar 2025Filings record

    Director or officer change

  9. 18 Oct 2024Insiders record

    BONDERMAN DAVID (ten percent owner) and 3 other(s) bought 380,268 shares of CBLL ($6.5M) (dated 17 Oct 2024)

  10. 17 Oct 2024Insiders record

    Tammenoms Bakker Juliet (director) bought 237,234 shares of CBLL ($4.0M) (dated 16 Oct 2024)

  11. 9 Oct 2024Filings record

    Registered new securities for sale (S-1)

  12. 7 Oct 2024Filings record

    Registered new securities for sale (S-1)

  13. 19 Sep 2024Filings record

    Registered new securities for sale (S-1)

  14. 26 Aug 2024Filings record

    Registered new securities for sale (S-1)

  15. 7 May 2021Filings record

    Private placement of securities (Form D)

Not listed: 104 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001861107
Ticker
CBLL
Domain
ceribell.com
Employer name
Ceribell, Inc. (1 unverified)
Hq location
CA|SUNNYVALE|94085 (1 unverified)
Name
CeriBell, Inc.
Uei
DTFEVJUKBV74
  • DOL H-1B labor condition applications and PERM certifications103 data points16 Mar 2020 to 20 Jul 2026
  • SEC Form 13F institutional holdings72 data points31 Dec 2024 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)35 records7 May 2021 to 3 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)262 data points31 Dec 2022 to 30 Oct 2026
  • SEC Form 4 insider transactions80 records, 228 data points16 Oct 2024 to 17 Nov 2026
  • FINRA short interest (twice monthly)149 data points15 Oct 2024 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)1060 data points11 Oct 2024 to 20 Nov 2026
  • USASpending.gov federal awards60 data points12 Apr 2018 to 13 Oct 2026